JAM2 and neoplasm: Like TAMs in the primary tumor, MAMs in metastatic sites also produce proteases to aid tumor cell invasion, such as cathepsin S, which has been shown to degrade the JAM-B junctional adhesion molecule in the blood–brain barrier and enhance breast–brain metastasis in both murine models and patients [118].